Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
Clinical trial NCT02340156 · TERMINATED
Trial details
- NCT number
- NCT02340156
- Sponsor
- SynerGene Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2018-11-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.